MARKET

FBIO

FBIO

Fortress Biotech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.300
0.000
0.00%
After Hours: 1.290 -0.01 -0.77% 17:45 10/17 EDT
OPEN
1.300
PREV CLOSE
1.300
HIGH
1.390
LOW
1.280
VOLUME
175.53K
TURNOVER
--
52 WEEK HIGH
2.590
52 WEEK LOW
0.4900
MARKET CAP
89.76M
P/E (TTM)
-1.1631
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of FBIO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

FBIO News

  • Mustang Bio Announces City of Hope Receives $4.1 Million in Grant Awards for Recently Opened First-of-Its-Kind Clinical Trial for Patients with Recurrent Malignant Glioma
  • GlobeNewswire.10/10 13:00
  • Fortress Biotech Preferred: Another Look At This Speculative 11.5% Yielder With More Cash Than Debt
  • Seeking Alpha - Article.10/02 21:51
  • 18 Healthcare Stocks Moving In Monday's Pre-Market Session
  • Benzinga.09/30 12:45
  • Checkpoint Therapeutics Announces Presentation of Positive Interim Clinical Results for Anti-PD-L1 Cosibelimab at the European Society for Medical Oncology (ESMO) Congress 2019
  • GlobeNewswire.09/30 12:30

More

Industry

Pharmaceuticals
+0.54%
Pharmaceuticals & Medical Research
+0.61%

Hot Stocks

Name
Price
%Change

About FBIO

Fortress Biotech, Inc.(Fortress) is a biopharmaceutical company that acquires, develops and commercializes novel pharmaceutical and biotechnology products. Fortress develops and commercializes products both within Fortress and through certain of its subsidiary companies. Fortress has 11 operating subsidiaries that include: 4 commercial stage programs, 25 development stage programs, targeting 6 therapeutic areas: Immuno-oncology, Hematology, Gene Therapy, Pain Management, Rare Diseases and Dermatology. In addition to its internal development programs, Fortress leverages its biopharmaceutical business expertise and drug development capabilities and provides funding and management services to help the Fortress Companies. Fortress subsidiaries include Aevitas Therapeutics, Avenue Therapeutics, Caelum Biosciences, Cellvation, Inc., Checkpoint Therapeutics, Cyprium Therapeutics, Helocyte, Inc., Journey Medical Corporation, Mustang Bio and Tamid Bio, Inc.
More

Webull offers Fortress Biotech Inc (FBIO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.